Effects of L-carnitine on treatment outcomes of COVID-19 patients hospitalized in intensive care units:A double-blind randomized clinical trial

Objective:To assess the effects of L-carnitine on the outcomes of patients with moderate to severe coronavirus disease 2019(COVID-19)in intensive care unit(ICU).Methods:This double-blind clinical trial was carried out in 2022-2023.64 Patients with COVID-19 were selected from Amiralmomenin and Khansari hospitals in Arak,Iran.They were randomly assigned to the control and the L-carnitine treatment group via block randomization.Venous blood gases,disease severity,and levels of D-dimer,lactate dehydrogenase,ferritin,and C-reactive protein were daily assessed during the seven days of the intervention,and the length of ICU stay,the need for endotracheal intubation,and mortality rate were documented.Results:There were significant differences in length of ICU stay,the need for endotracheal intubation,and levels of D-dimer,lactate dehydrogenase,ferritin,APACHE栻score,and C-reactive protein between the two groups(P<0.05).However,the groups did not significantly differ in mortality rate and venous blood gas indexes(P>0.05).Conclusions:L-carnitine can improve outcomes of patients with COVID-19.Therefore,it can be used as an adjuvant therapy for these patients.

Effects of L-carnitine on Population Growth of Nannochloropsis oculata and Tetrahymena sp.

[Objective] The aim was to study the effects of L-carnitine on population growth of Nannochloropsis oculata and Tetrahymena sp..[Method] When the concentration of L-carnitine was 0,50,100 and 1 000 mg/L,population densities of Nannochloropsis oculata and Tetrahymena were determined respectively.[Result] Adding high-dose L-carnitine had a significant inhibition effect on the population growth of Nannochloropsis oculata （P0.05）.Adding L-carnitine had a significant proliferation promoting effect on the population growth of Tetrahymena （P0.05）.[Conclusion] The research provides theoretical basis for the application of L-carnitine as feed additive in aquaculture.

维生素D治疗全面性发育迟缓患儿的临床疗效研究

背景 除了某些有明确病因的代谢性疾病导致的全面性发育迟缓(GDD),康复治疗是GDD的主要治疗方式;维生素D通过影响神经营养因子在调节神经细胞的发育和分化方面发挥着重要的神经保护作用;但目前关于补充维生素D对GDD患儿临床疗效的研究开展较少。目的 探讨补充不同剂量的维生素D对GDD患儿康复治疗的临床效果。方法 于2020年9月—2022年6月选取在郑州大学第三附属医院康复医学科首次住院就诊的120例GDD患儿为研究对象,采用随机区组化的方法将其分为常规组(38例)、400 U组(37例)和1 200 U组(35例)。常规组仅进行常规康复治疗;400 U组在常规康复治疗的基础上给予口服400 U/d维生素D;1 200 U组在常规康复训练的基础上给予口服1 200 U/d维生素D。收集3组患儿的性别、就诊年龄等基本资料;于入院时(治疗前)及第3个疗程末(治疗后)行血清25羟维生素D[25(OH)D]水平检测和Gesell发育量表评估[评估适应能力、大运动能力、精细运动能力、语言能力和社交能力5个能区的发育商(DQ)];记录发生在患儿住院期间不良事件的次数,并对上述资料进行分析比较。结果 3组患儿性别、居住地、出生季节、分娩方式、就诊年龄、出生体质量、出生胎龄、主要就诊原因比较,差异均无统计学意义(P>0.05)。治疗前,3组患儿25(OH)D水平、Gesell量表各能区DQ值比较,差异均无统计学意义(P>0.05);治疗后,1 200 U组患儿血25(OH)D水平、Gesell量表大运动能力、精细运动能力、语言能力DQ值高于常规组(P<0.05)。第1、2疗程期间,3组患儿不良事件发生率比较,差异无统计学意义(P>0.05);第3疗程期间,1 200 U组患儿不良事件发生率低于常规组及400 U组(P<0.05)。结论 补充1 200 U维生素D对GDD患儿的康复疗效有益,且能减少康复期间不良事件的发生率。

绝经后女性维生素D水平与生殖特点和运动膳食情况的关系

背景:研究证明绝经后骨质疏松症与女性生殖特点和运动膳食有关,但是鲜有研究证明女性生殖特点及运动膳食是否对绝经后女性维生素D有影响。目的:探讨北京市绝经后女性维生素D水平与女性生殖特点和运动膳食情况的关系及其影响因素。方法:选取2017年9月至2018年5月北京市多个城区的17个社区现场问卷调查的727例46-75岁绝经后女性作为研究对象,问卷内容包括受试者的基本信息和月经史、绝经史、妊娠史、运动膳食情况等。采用电化学发光免疫分析仪及其配套试剂测定25-(OH)D水平;使用双能X射线骨密度检测仪测定腰椎(L1-L4、整体)和双髋关节(股骨颈、整体)的骨密度和T值;观察维生素D与生殖特点和运动膳食的相关性,并进行维生素D的影响因素分析。结果与结论:①维生素D正常组136例(18.7%),维生素D不足组389例(53.5%),维生素D缺乏组202例(27.8%);平均维生素D水平为(15.60±5.85)ng/mL。②随着维生素D水平的升高,不同部位的骨密度值及T值也随之升高。③维生素D水平与初潮年龄、月经持续天数、绝经阶段、运动情况、饮食类型、饮食偏好均呈正相关(P<0.05);与月经周期、绝经年龄、生育次数均呈负相关(P<0.05);与初孕年龄、怀孕次数无相关性(P>0.05)。④多因素有序Logistic回归分析结果显示,喝奶制品频率对绝经后女性维生素D值存在正向相关(P<0.05),且奶制品是维生素D水平的保护因素。⑤调查结果说明,北京市绝经后女性维生素D水平普遍不足、骨密度值普遍低下,维生素D水平与部分生殖特点、运动膳食情况存在关联,且其中喝奶制品是其保护因素。因此可以通过开展相关骨质疏松的健康教育,对绝经后女性膳食情况进行调整加以干预,增加体内维生素D含量,以期增加骨密度值,减少绝经后骨质疏松患病率。

L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin

AIM：To evaluate the efficacy of L-carnitine on alleviating anemia,thrombocytopenia and leukopenia,and minimizing dose reductions in patients with chronic hepatitis C virus（HCV）in treatment with Interferonα（IFN-α）plus ribavirin.METHODS：Sixty-nine patients with chronic hepatitis C were enrolled in the study and divided into two groups.group A（n=35）received Peg-IFN-α2b plus ribavirin plus L-carnitine,and group B（n=34）received Peg-IFN-αand ribavirin for 12 mo.All patients underwent laboratory investigations including：red cell count,he-moglobin,white cell count,platelets,bilirubin,alanineaminotransferase（ALT）,aspartate aminotransferase（AST）,and viremia.RESULTS：After 12 mo in group A compared to group B we observed significant differences in AST 108.8 vs 76.8（IU/L;P0.001）,ALT 137.vs 112.3（IU/L;P 0.001）,viremia 4.04 vs 2.36（106 copies/mL;P 0.001）,Hb 1 vs 3.5（g/dL;P0.05）,red blood cells 0.3 vs 1.1（1012/L;P0.001）,white blood cells 1.5 vs 3（10/L;P0.001）and platelets 86 vs 85（×10/L;P0.001）.The end treatment responders were 18 vs 12（60%vs 44%）and the non responders were 12 vs 15（40%vs 50%）[odds ratio（OR）1.65,5%CI =0.65-5.37,P0.05.In group A compared to group B there was a significant improvement of sustained vi-rological response in 15 vs 7 patients（50%vs25%）,while the relapsers were 3 vs 5（10%vs 18%）（OR 3.57,5%CI=0.65-1.3,P0.001）.CONCLUSION：L-carnitine supplementations modulate erythropoiesis,leucopoiesis and thrombocytopoiesis,and may be useful in patients treated for HCV.L-carni-tine treatment offers the possibility of achieving a sus-tained virological response while preventing overtreat-ment.

Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis

AIM: To investigate the beneficial effect of the combination of butyrate, Lactobacillus casei, and L-carnitine in a rat colitis model.

Development and validation of a UPLC–MS/MS assay for the determination of gemcitabine and its L-carnitine ester derivative in rat plasma and its application in oral pharmacokinetics

A simple and rapid UPLC–MS/MS method to simultaneously determine gemcitabine and its L-carnitine ester derivative(2’-deoxy-2’, 2’-difluoro-N-((4-amino-4-oxobutanoyl) oxy)-4-(trimethyl amm-onio) butanoate-cytidine, JDR) in rat plasma was developed and validated.The conventional plasma sample preparation method of nucleoside analogues is solidphase extraction(SPE) which is time-consuming and cost-expensive. In this study, gradient elution with small particles size solid phase was applied to effectively separate gemcitabine and JDR, and protein precipitation pretreatment was adopted to remove plasma protein and extract the analytes with high recovery(>81%). Method validation was performed as per the FDA guidelines, and the standard curves were found to be linear in the range of 5–4000 ng/ml for JDR and 4–4000 ng/ml for gemcitabine, respectively. The lower limit of quantitation(LLOQ)of gemcitabine and JDR was 4 and 5 ng/ml, respectively. The intra-day and inter-day precision and accuracy results were within the acceptable limits. Finally, the developed method was successfully applied to investigate the pharmacokinetic studies of JDR and gemcitabine after oral administration to rats.

Enantiomeric Resolution on L-Carnitine Selective Polymers Prepared by Molecular Imprinting

L-carnitine selective polymers were prepared by molecular imprinting using methacrylic acid as the functional monomer. The acid function of the monomer is expected to form hydrogen bond and ionic interactions with the amine function of the target molecule L-carnitine. The imprinted polymers were used as stationary phases in high-performance liquid chromatography (HPLC). It was shown that L-carnitine imprinted polymer exhibited a higher affinity to its template molecule, while the non-imprinted polymer had no affinity to the compounds tested. Racemic carnitine hydrochloride was efficiently resolved on the L-carnitine imprinted polymer, and the separation factor is 1.9.

L-carnitine alleviates sciatic nerve crush injury in rats:functional and electron microscopy assessments

Several studies have demonstrated that L-carnitine exhibits neuroprotective effects on injured sciatic nerve of rats with diabetes mellitus. It is hypothesized that L-carnitine exhibits neuro-protective effects on injured sciatic nerve of rats. Rat sciatic nerve was crush injured by a forceps and exhibited degenerative changes. After intragastric administration of 50 and 100 mg/kg L-carnitine for 30 days, axon area, myelin sheath area, axon diameter, myelin sheath diameter, and numerical density of the myelinated axons of injured sciatic nerve were similar to normal, and the function of injured sciatic nerve also improved signiifcantly. These ifndings suggest that L-carnitine exhibits neuroprotective effects on sciatic nerve crush injury in rats.

Effect of L-carnitine on Cardiomyocyte Apoptosis and Cardiac Function in Patients Undergoing Heart Valve Replacement Operation

Summary： The effects of L-carnitine, as an ingredient of cardioplegia solution, on cardiac function and cardiomyocyte apoptosis in patients undergoing heart valve replacement operation were investigated. Twenty-three cases undergoing heart valve replacement with cardiopulmonary bypass （CPB） were randomly allocated into two groups： L-carnitine group （n=12, 12 g/L L-carnitine was put in the ST. Thomas cardioplegia） and control group （n=11, identical to the L-carnitine group except that normal saline was administered instead of L-carnitine）. Serum cardial troponin I （cTnI） levels, the left ventricular ejection fraction （LVEF）, and cardiac index （CI） were measured perioperatively. A bit of myocardial tissue obtained from right atria was taken before CPB and by the end of intracardiac procedure to undergo electron microscopy examination and estimate apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling （TUNEL）. From the end of CPB to 3 days after operation, the serum levels of cTnI in the L-carnitine group was significantly lower than that in the control group （P〈0.05）. Heart color ultrasonogram showed that the CI index and LVEF at 7th day postoperatively in the L-carnitine group were significantly higher than in the control group （P〈0.05）. Compared to the control group, L-carnitine significantly alleviated the morphologic changes of cardiac muscle cells （electron microscopy examination） and decreased the amounts of apoptotic cardiac muscle cells （TUNEL）. Furthermore, the dosage of vasoactive drugs used after operation was significantly less in the L-carnitine group （P〈0.01）. It was concluded that L-carnitine cardioplegia solution could improve cardiac function in patients undergoing heart valve replacement operation and alleviate CPB-mediated apoptosis of cardiac muscle cells.

L-carnitine supplementation in non-alcoholic fatty liver disease: A systematic review and meta-analysis

BACKGROUND Non-alcoholic fatty liver disease(NAFLD)dominates the landscape of modern hepatology.Affecting 25%of the general population,there is critical unmet need to identify broadly available,safe and cost-effective treatments.Cumulative evidence in animal and human models suggests that intrahepatic and skeletal muscle fatty acid oxidation is impaired in NAFLD,such that lipid accretion is not matched by efficient utilisation.L-carnitine is a crucial mediator of fatty acid metabolism in vivo,promoting mitochondrial lipidβ-oxidation and enhancing tissue metabolic flexibility.These physiological properties have generated research interest in L-carnitine as a potentially effective adjunctive therapy in NAFLD.AIM To systematically review randomised trials reporting effects of dietary L-carnitine supplementation on liver biochemistry,liver fat and insulin sensitivity in NAFLD.METHODS Search strategies,eligibility criteria and analytic methods were specified a priori(PROSPERO reference:CRD42018107063).Ovid MEDLINE,Ovid EMBASE,PubMed,Web of Science and the Cochrane Library were searched from their inception until April 2019.Outcome measures included serum concentrations of alanine and aspartate aminotransferase(ALT and AST),liver fat and insulin sensitivity assessed by the homeostasis model of insulin resistance(HOMA-IR).A random effects meta-analysis was performed for,ALT,AST and HOMA-IR measures separately.Between-study heterogeneity was measured using I2 statistics.RESULTS Five eligible randomised trials were included in the qualitative and quantitative synthesis(n=338).All of the 5 included trials assessed the effect of L-carnitine on serum ALT,identified from Italy,South Korea and Iran.Weighted mean difference(WMD)for ALT between L-carnitine and control groups after intervention was-25.34 IU/L[95%CI:-41.74-(-8.94);P=0.002].WMD for AST between L-carnitine and control groups was-13.68 IU/L(95%CI:-28.26-0.89;P=0.066).In three studies(n=204),HOMA-IR was evaluated.WMD for HOMA-IR between L-carnitine and control groups was-0.74 units[95%CI:-1.02-(-0.46);P<0.001].Two studies using validated outcome measures reported a significant reduction in liver fat in L-carnitine vs control groups post-intervention(P<0.001).CONCLUSION Pooled results indicate that L-carnitine supplementation attenuates ALT,liver fat and insulin resistance in NAFLD cohorts,confirming a beneficial effect of Lcarnitine for a highly prevalent condition with a growing economic burden.

3D打印技术在创伤性骨折中的应用

背景:3D打印技术可根据患者实际病情和治疗需求设计构建模型、手术导板和个性化植入体或固定物,在创伤性骨折修复中展示了巨大的应用前景。目的:综述3D打印技术在创伤性骨折中的应用。方法:检索Web of science、PubMed和中国知网数据库2020-2024年发表的创伤骨科领域3D打印技术应用的相关文献,英文检索词为“traumatic fracture,3D printing technology,digital model,surgical guide”,中文检索词为“创伤性骨折,3D打印技术,数字模型,手术导板”,经筛选和分析,最终纳入60篇文献进行分析。结果与结论:①创伤性骨折是各种致伤因素导致的骨骼连续性中断和完整性破坏的骨折现象,以可靠方案提高复位愈合效果,已成为骨外科相关研究领域亟需解决的热点问题;②3D打印技术是以数字模型数据为基础的,运用粉末状金属或聚合物等可黏合成型材料以立体光刻、沉积建模和光聚合物喷射等形式制造满足需求三维实体的技术,在数字骨科生物医学领域应用广泛;③3D打印技术在疾病诊断、术前规划、重建骨折三维模型、定制骨科植入体、定制固定支具及假肢、手术导板制作和骨缺损修复等方面发挥了显著的优势,可根据患者实际病情和治疗需求设计构建模型、手术导板和个性化植入体或固定物,为创伤性骨折的治疗提供了新的思路。

Gyroid结构钛仿生骨支架修复下颌骨节段性缺损的生物力学性能

背景:三周期最小表面的多孔结构是最有前景的骨科生物结构之一,其中的Gyroid结构具有高比表面积、高渗透率、均曲率为零等特点。目的:通过有限元分析结合力学压缩实验测试,筛选出与下颌骨松质骨弹性模量范围相匹配的4 mm单胞Gyroid结构TC4仿生骨支架壁厚区间。方法:建立不同壁厚(0.1,0.2,0.3,0.4,0.5,0.6,0.7,0.8 mm)4 mm单胞Gyroid结构有限元模型,分析Gyroid结构的等效弹性模量,筛选出与下颌骨松质骨弹性模量范围相匹配的Gyroid结构壁厚区间,壁厚分别为0.2,0.3,0.4,0.5,0.6,0.7 mm。根据有限元分析筛选结果,以Ti6Al4V为原料,采用选择性激光熔融技术制备不同壁厚的3D打印Gyroid结构试件,进行大颗粒喷砂酸蚀处理,通过力学压缩实验测试试件的弹性模量与抗压强度。结果与结论:(1)有限元分析结果显示,随着壁厚的增加,Gyroid结构的等效弹性模量升高,其中壁厚为0.2-0.7 mm Gyroid结构的等效弹性模量在下颌骨松质骨弹性模量范围内(1.5-4.0 GPa),用于3D打印Gyroid结构试件;(2)力学压缩实验结果显示,随着壁厚的增加,Gyroid结构试件的弹性模量与抗压强度均升高,其中0.3-0.5 mm壁厚Gyroid结构试件的弹性模量在下颌骨松质骨弹性模量范围内,0.3-0.7 mm壁厚Gyroid结构试件的抗压强度符合下颌骨的力学性能;(3)结果显示0.3-0.5 mm壁厚Gyroid结构与下颌骨的弹性模量范围相适应。

亲水性Gyroid结构种植体的制备及力学性能分析

背景:传统实心钛合金种植体的弹性模量高于人骨,由此引起的“应力屏蔽”现象可能会影响种植体的骨结合,同时3D打印钛合金表面的亲水性有待提高。目的:制备生物力学性能优良的亲水性Gyroid结构种植体。方法:建立Gyroid结构种植体、实心结构种植体、下颌骨骨块和牙冠的3D模型,对不同结构种植体的力学性能进行有限元分析。将Gyroid结构种植体模型导入3D打印机,使Gyroid结构种植体实体化,然后对种植体表面依次进行喷砂酸蚀和紫外光功能化处理,制备具有优良力学性能和表面活性的亲水性Gyroid结构种植体。通过扫描电镜和接触角测试分析3D打印Ti6Al4V试件表面改性处理前后的形貌与亲水性。结果与结论:①有限元分析结果显示,在垂直向平均咬合力作用下,Gyroid结构可以将作用于种植体上的载荷均匀分散到整个结构中,实心结构种植体上的载荷只能分散在其外表面并集中于颈部;Gyroid结构种植体受到的最大等效应力为200.67 MPa,不超过Ti6Al4V材料屈服强度的50%;Gyroid结构种植体对周围骨组织的最大等效应力为24.27 MPa,略高于实心结构种植体的最大等效应力17.32 MPa,并且在20-60 MPa区间内,Gyroid结构种植体对新骨形成的刺激效果优于实心结构种植体。②3D打印技术可以将Gyroid结构种植体模型实体化,扫描电镜下可见3D打印Ti6Al4V试件表面有许多未熔融的球形金属颗粒,经喷砂酸蚀后表面形成微米级网状孔洞结构,已不见凸出的金属颗粒,紫外光功能化处理+喷砂酸蚀处理的试件表面形貌与喷砂酸蚀组基本一致;接触角测试结果显示,紫外光功能化处理+喷砂酸蚀处理后的试件表面亲水性优于喷砂酸蚀处理组与无表面处理组。③喷砂酸蚀处理可以去除3D打印试件上弱连接的金属颗粒,提高实体模型与设计模型的相似性,在此基础上进行紫外光功能化处理可以显著提高3D打印Gyroid结构种植体的亲水性且不影响其结构。

3D打印个体化截骨导板结合定制钢板在开放楔形胫骨高位截骨中的应用

背景:3D打印个体化截骨导板辅助开放楔形胫骨高位截骨治疗膝骨关节炎具有手术时间短、透视次数少、矫正精准度高等优点。但之前报道的截骨导板对周围软组织破坏严重、锁定钢板位置不当等问题依旧明显。目的:探究3D打印个体化截骨导板结合定制钢板辅助开放楔形胫骨高位截骨治疗膝骨关节炎的临床疗效。方法:收集20例确诊为膝骨关节炎的患者,按手术方法分为3D组和常规组,每组10例。3D组采用3D打印个体化截骨导板结合定制钢板辅助开放楔形胫骨高位截骨手术,常规组进行常规开放楔形胫骨高位截骨手术。分析比较两组患者手术时间、透视次数、切口长度,术前和术后髋膝踝角、胫骨近端内侧角、胫骨后倾角以及计划矫正角度与实际矫正角度的差值,术前和术后1,3,6个月膝关节活动度及Lysholm评分,另外记录并发症发生情况。结果与结论:①3D组患者的手术时间、透视次数少于常规组,差异有显著性意义(P<0.001);②两组患者的术后髋膝踝角、胫骨近端内侧角均较术前增大,差异有显著性意义(P<0.001),而胫骨后倾角无明显改变;3D组术后髋膝踝角、胫骨近端内侧角及胫骨后倾角与术前计划值分别相差(-0.22±0.72)°、(-0.20±0.73)°和(0.23±0.37)°,但差异均无显著性意义;3D组计划矫正度数与实际矫正度数的差值较常规组小,差异有显著性意义(P<0.05);③两组患者术后膝关节活动度及Lysholm评分均逐步升高(P<0.001);3D组术后1,3个月的膝关节活动度及术后1个月的Lysholm评分优于常规组,差异有显著性意义(P<0.05);两组患者术后3个月的Lysholm评分、术后6个月的膝关节活动度及Lysholm评分差异无显著性意义(P>0.05);④两组患者均无并发症发生;⑤上述结果说明3D打印个体化截骨导板结合定制钢板辅助和常规方法均有良好的临床疗效,但前者的手术时间更短,透视次数更少,术后膝关节功能恢复更快;并且3D打印个体化截骨导板可精准实现术前规划。

Antioxidant Effects of L-carnitine on Rabbit

[ Objective] The paper was to study antioxidant effects of L-carnitine （LC） on rabbit, and explore its impact on SOD, GSH-PX, CAT, T-AOC and MDA activity in the plasma, brain tissue and cerebrospinal fluid of rabbit. [ Method] The healthy matured New Zealand rabbits with big ears were intragastrically administrated with LC at the dose of lmL/kg, and SOD, GSH-PX, CAT, T-AOC and MDA activities in plasma, brain tissue and cerebrospinal fluid of rabbit were determined at different periods before and after administration, respectively. [Result] After LC administration, SOD, GSH-PX CAT, and T-AOC activity in plasma, brain tissue and cerebrospinal fluid increased significantly （P 〈 0.05 ）, while MDA content decreased significantly （P 〈 0.05）. [Condusion ] LC oral solution shows antioxidant effects on rabbit.

L-Carnitine Contents in the Tissues of Rabbits Fed Urea as an Alternative of Dietary Protein

The present study was aimed to observe the effects of urea ingestion, non-protein nitrogen, on the disorder of nitrogen metabolism with the L-carnitine contents using the blood, kidney, liver, and femoral muscle as markers. A total of 8 Japanese white rabbits were used in this experiment. They were fed a basal diet prepared for the control group and the nitrogen volume proportionated to one-third of CP 14%, was replaced with urea in the feed of the experimental group for 7 days. On the final day, the animals were fasted from the previous evening and sacrificed. Blood was collected into a test tube at the same time of the sacrifice and their heart, kidney, liver and femoral muscle were collected. The L-carnitine contents in each sample and the urea in the blood were determined. The results of the growth test showed that there was no significant difference. Furthermore, there was no significant difference in the contents of L-carnitine and urea in each sample. It was concluded that nitrogen replacement of the diet with urea, in the range of 1/3 of dietary protein, had neither effect on the maintenance of body weight nor nitrogen balance, including the de novo synthesis of L-carnitine.

Effects of L-carnitine on Blood Lipid Metabolism and Antioxidation in Hyperlipidemia Rats

[Objective] To study the effects of L-carnitine （LC） on lowering the high blood lipid and antioxidation in hyperlipidemia rats. [Method] 50 healthy SD rats were randomly divided into 5 groups. They were fed with standard diet, high-cholesterol diet and high-cholesterol diet with 0.25, 0.5, 1.0 g/（ kg · d） LC. After the LC groups were consecutively orally administered LC for 28 days, rat serum total cholesterol （ TC）, triglyceride （TG）, high density lipoprotein （ HDL-C）, low density lipoprotein （LDL-C） content, as well as super oxide dismutase （SOD） activity and malondial- dehyde （MDA） content in serum and liver were determined. [ Reset~ Compared with the high-fat model group, LC could significantly reduce the se- rum TC, TG, LDL-C levels, increase HDL-C level, and enhance SOD activity in serum and liver, decrease the content of MDA （ P 〈0.05）. [ Con- Clusion] LC might have a significant role in lowering the high blood lipid and improving internal antioxidant capacity in hyperlipidemia rats.

3D打印个性化正畸装置对单根牙垂直移动的三维有限元分析

背景:基于牙齿垂直移动原理,通过数字化设计结合3D打印制作个性化正畸装置,可使个性化正畸装置与单个切牙形成支抗系统。借助微种植体绝对支抗作用可对单根牙在三维方向上进行精准控制。目的:基于生物力学原理设计了牙位11、12、21、22压低移动与伸长移动的个性化正畸装置,通过三维有限元法分析个性化正畸装置的安全性与其对牙齿的移动作用。方法:应用Mimics、Geomagic Wrap、SolidWorks和Ansys Workbench软件分别建立了上颌前牙区(牙位11、12、21、22)牙槽骨-牙周膜-上颌切牙-个性化悬臂微种植体-连接板-个性化托槽的三维有限元模型,每个牙位分别设置个性化压低移动与伸长移动正畸装置,加载300 g拉力或推力,分析个性化正畸装置各部件应力水平,计算牙齿位移与牙周膜应力分布情况。结果与结论:①个性化压低移动正畸装置受到的最大等效应力为162.90 MPa,个性化伸长移动正畸装置受到的最大等效应力239.57 MPa,二者的最大等效应力均位于个性化托槽加力附件的垂直部分,个性化正畸装置各部件所受等效应力均在屈服强度内,均具有良好的安全性;②在个性化正畸装置作用下,牙齿初始位移呈现整体压低或伸长移动的趋势,垂直方向上的位移远远超过在水平方向和矢状方向上的位移;牙周膜根尖或颈部位置出现等效应力峰值,在根尖区牙周膜出现等效应力集中区域;③结果显示,个性化正畸装置可以使牙位11、12、21、22近似达到压低移动或伸长移动的目的,初步证实了个性化垂直移动正畸装置的有效性。

L-carnitine improves developmental competence of buffalo oocytes in vitro

Objective:To investigate the effect of L-carnitine on in vitro maturation and subsequent in vitro embryo production of buffalo oocytes.Methods:Cumulus oocyte complexes(COCs)were aspirated from ovaries of slaughtered buffaloes.COCs were classified into good and fair qualities based on morphological observation of numbers and integrity of cumulus cells surrounding the oocyte.Both categories of COCs were placed in in vitro maturation medium with supplementation of different concentrations(0,0.250,0.375 or 0.500 mg/mL)of L-carnitine.Oocytes from both qualities were in vitro fertilized and in vitro cultured for 7 days,to examine the developmental competence.Results:Supplementation of L-carnitine to in vitro maturation medium increased the cumulus cell expansion rate of COCs to grade A,and reduced the cumulus cell expansion of COCs to grade B and grade C in both good and fair quality oocytes.Similarly,L-carnitine induced the in vitro meiotic progression of buffalo oocytes to metaphaseⅡin both good and fair quality oocytes.Additionally,L-carnitine reduced the rate of oocyte degeneration in both good and fair quality oocytes.L-carnitine increased the rate of cleaved formation at day 2 and blastocyst formation at day 7 during in vitro culture in both qualities of oocytes.Moreover,a higher rate of blastocyst production was observed in L-carnitine-treated fair quality oocytes,which was higher than the results in the untreated good quality oocytes.Conclusions:L-carnitine enhances meiotic maturation and subsequent embryo development from both good and fair quality buffalo oocytes.